These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6779325)

  • 1. Log dose/response curve flattening in rats after daily injection of opiates.
    Mucha RF; Kalant H
    Psychopharmacology (Berl); 1980; 71(1):51-61. PubMed ID: 6779325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of tolerance to morphine after a change in route of administration: control of within-session tolerance by interoceptive conditioned stimuli.
    Mucha RF; Kalant H; Birbaumer N
    Psychopharmacology (Berl); 1996 Apr; 124(4):365-72. PubMed ID: 8739552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tolerance to the intestinal inhibitory effect of opiates in mice.
    Petersen DW; Fujimoto JM
    Eur J Pharmacol; 1983 Nov; 95(3-4):225-30. PubMed ID: 6653671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone prevention of morphine LDR curve flattening associated with high-dose tolerance.
    Mucha RF; Kalant H
    Psychopharmacology (Berl); 1981; 75(2):132-3. PubMed ID: 6798602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intrinsic efficacy on opioid tolerance.
    Duttaroy A; Yoburn BC
    Anesthesiology; 1995 May; 82(5):1226-36. PubMed ID: 7741298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
    Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline analgesia following central administration of opioids.
    Ossipov MH; Goldstein FJ; Malseed RT
    Neuropharmacology; 1984 Aug; 23(8):925-9. PubMed ID: 6483117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effects of prolyl-leucyl-glycinamide on morphine-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Eur J Pharmacol; 1984 Jun; 102(1):13-22. PubMed ID: 6148243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unidirectional non-cross-tolerance (UNCT) in rats and an apparent dissociation between narcotic tolerance and physical dependence.
    Roerig SC; Fujimoto JM; Franklin RB; Lange DG
    Brain Res; 1985 Feb; 327(1-2):91-6. PubMed ID: 4039210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
    Lange DG; Roerig SC; Fujimoto JM; Busse LW
    J Pharmacol Exp Ther; 1983 Jan; 224(1):13-20. PubMed ID: 6681541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential analgesic cross-tolerance to morphine between lipophilic and hydrophilic narcotic agonists.
    Paktor J; Vaught JL
    Life Sci; 1984 Jan; 34(1):13-21. PubMed ID: 6141509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross tolerance to etorphine in rats tolerant to morphine-induced antidiuresis.
    Fuhrman-Lane C; Tseng LF; Fujimoto JM
    Life Sci; 1982 Jun; 30(26):2317-23. PubMed ID: 7109848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
    Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
    Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body temperature effects of opioids in rats: intracerebroventricular administration.
    Geller EB; Rowan CH; Adler MW
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1761-5. PubMed ID: 2942949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1012-21. PubMed ID: 11082436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance to hyperthermia produced by morphine in rat.
    Mucha RF; Kalant H; Kim C
    Psychopharmacology (Berl); 1987; 92(4):452-8. PubMed ID: 3114798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor regulation in mice.
    Yoburn BC; Billings B; Duttaroy A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats.
    Walker EA; Young AM
    Psychopharmacology (Berl); 2001 Mar; 154(2):131-42. PubMed ID: 11314675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.